Introduction {#S1}
============

The pathogen; porcine reproductive and respiratory syndrome virus (PRRSV), as well as other members, for example, EAV, LDV, and SHFV, belong to the large family of Arteriviridae, which is made up of enveloped, positive-strand RNA viruses ([@B93]). PRRSV exists as two distinct virus species, i.e., PRRSV-1 (prototype Lelystad)\_ and PRRSV-2 (prototype VR-2332), and the genome is about 15 kb in length, and they share ∼60% nucleotide identity (2016)^[1](#footnote1){ref-type="fn"}^ ([@B104]). PRRSV is the pathogen of Porcine reproductive and respiratory syndrome (PRRS). It is the leading cause of pregnancy wastages and piglet mortality in swine herds. The current commercially available inactivated and MLV cannot provide full protection against the genetically diverse strains in the field in most cases ([@B103]), and MLV have the potential of reverting to more virulent forms, which cause more infection than prevention ([@B74]; [@B84]). Besides, the humoral and cell-mediated immune (CMI) responses elicited by PRRSV-MLVs is delayed and relatively weak ([@B30]; [@B189]). For example, it takes a delayed period of 28--30 days for the PRRSV-specific neutralizing antibodies (NA) responsible for the clearance of PRRSV from the pigs to appear after vaccination with a relatively low titer (usually between 8 and 32) ([@B28]). T cell response to PRRSV-MLVs is extremely delayed compared with T cell response to other RNA viruses. That of PRRSV appears in about 7--14 days and peaks between 220 and 224 days after vaccination, while that of pseudorabies virus (PRV)is observed within 7 days of vaccination and peaks approximately within 28--30 days after vaccination ([@B102]). Furthermore, PRRSV-MLV vaccinated pigs can develop viremia for up to 30 days after vaccination, increasing the risk of vaccine virus transmission to naive animals ([@B19]; [@B160]). The induction of antibody-dependent enhancement (ADE) of infection has also be reported in herds vaccinated with MLV ([@B66]; [@B186]). Thus, the need for an alternative therapy that is potent, inexpensive, efficient and effective against PRRSV is critically urgent. PRRSV infection is highly restricted to cells *in vitro* and *in vivo*. PRRSV infection in the host cells referred to the four stages: entry (attachment and internalization), uncoating, nucleic acid or protein synthesis, assembly, and viral release ([@B75]). Viral attachment to putative receptors expressed at the cell surface is the first phase in the process of viral entry into susceptible cells. Molecules or factors including HS, vimentin, cluster of differentiation 151 (CD151), CD163, sialoadhesin (CD169, Sn), DC-SIGN (CD209), and non-muscle myosin heavy chain 9 (MHC II-A or MYH9) are among the several proteins described as putative receptors for PRRSV ([@B45]; [@B93]).

PRRSV Infection {#S1.SS1}
---------------

Pigs are the natural host of PRRSV, and the virus infects a narrow range of cells, both *in vitro* and *in vivo* due to the presence of putative receptors in these cells. Porcine alveolar macrophages and blood monocytes are the only porcine cells known to be susceptible to PRRSV infection due to the abundant presence of putative receptors on the surfaces of these cells; however, some cells from the African green monkey kidney cell lines including CL2621, MA-104, and MARC-145 are used for research and propagation of PRRSV *in vitro* because they express varying levels of PRRSV receptors thereby supporting infection by the virus. These receptors play significant roles during PRRSV infection of cells since they can be involved in the virus binding, internalization or uncoating. Among these, CD163 is indispensable for positive infection ([@B45]) and SIGLEC1 or CD169 is not necessary for PRRSV infection ([@B120]), see [Figure 1](#F1){ref-type="fig"}.

![Roles of putative receptors in PRRSV infectivity. **(A)** Cell without receptors shows no susceptibility. **(B)** The expression of HS could only result in viral attachment. **(C)** CD169 promotes attachment and internalization without resultant infection. **(D)** There is neither attachment nor infection in the absence of CD169 and CD163. **(E)** The presence of CD163 alone changed non-permissive cell to permissive cell and results in positive infection.\
Key: Heparan Sulfate (HS) = ![](fmicb-11-01756-i001.jpg) Sialoadhesin (CD169) = ![](fmicb-11-01756-i002.jpg) Cluster of Differentiation (CD163) = ![](fmicb-11-01756-i003.jpg).](fmicb-11-01756-g001){#F1}

The initial primary defense response of animals to viral infection is the production of interferon-alpha (IFN --α), (a type 1 interferon), often followed by inflammatory cytokines such as tumor necrosis factor (TNF) and interleukin-1 (IL-1). However, with PRRSV infection, such response is weakened or significantly suppressed. Some authors have stated that the expression of IFN --α inhibits the replication of viruses, including PRRSV *in vitro* ([@B4]; [@B183]; [@B14]). The expression of inflammatory cytokine plays a very significant role in the organization of the host immune system against a variety of viral infection ([@B14]). TNF, IL-1β, and IL-6 are essential activators of the nuclear transcription factor, NF-κB ([@B24]; [@B109]). The function of NF-κB during infection is to regulate the transcription of hundreds of genes, including antigen receptors, inflammatory and immunoregulatory cytokines, adhesion molecules, inhibitors of apoptosis, acute phase proteins, and innate effector molecules; for this reason, it was stated that the mild or subclinical respiratory abnormalities involved in PRRSV infection might be due to the lack of activation of NF-κB. However, when there is a lack of an acute inflammatory response and weak innate antiviral activity, the resultant effect may also be an incomplete stimulation of antigen-specific immune responses, leading to the establishment of persistent infection ([@B150]).

Besides, PRRSV is capable of evading type I interferon-mediated antiviral response by several mechanisms including the secretion of IL-10, a potent immunosuppressive cytokine which is capable of downregulating the host immune responses. It is also involved in encoding several IFN antagonists which block either IFN induction or IFN-activated JAK/STAT signaling ([@B116]; [@B161]; [@B176]). Then [@B21] stated that the sp1 of PRRSV generates two self-cleaved subunits: nsp1a and nsp1b. They both inhibited IFN-β expression by affecting IRF3-mediated IFN induction ([@B21]). Nsp2 is the most prominent non-structural protein encoded by PRRSV; it antagonizes IFN induction by blocking IRF3 phosphorylation and nuclear translocation. Researchers have also provided evidence that nsp4 is another IFN antagonist which interferes with the NF-κB signaling pathway through the cleavage of NEMO to weaken the IFN-β induced by poly (I:C) [@B57]. Furthermore, nsp11 can suppress the activation of IFN-β by cleaving the mRNA of IPS-1 via the endoribonuclease domain ([@B130]). Accumulating evidence has also reported that other than the nsps of PRRSV, structural proteins, such as N protein, prevent IFN-β induction like that of nsp2 ([@B126]). Apart from inhibiting IFN induction, PRRSV nsp1b also prevents IFN-activated JAK/STAT signaling via promoting degradation of KPNA1, an essential transporter for mediating the nuclear import of ISGF3 ([@B116]; [@B158]). Moreover, nsp7, nsp12, GP3, and N of PRRSV also interfere with IFN-activated signaling by an unknown mechanism ([@B159]; [@B176]). See [Figure 2](#F2){ref-type="fig"} for a simplified summary of activities of the innate and adaptive immune system against viral (PRRSV) infection.

![Immune response against viruses. **(A)** Innate immune response: NK cells initially recognize virus infection and evokes antiviral responses by producing Types I & II interferons (IFN-α/β/y). Type I interferons can initiate the activation of JAK/STAT signaling to induce hundreds of IFN-stimulated genes (ISGs), which help to eliminate virus-infected cells. **(B)** Adaptive immune production of antibodies against viral antigens. T CD8^+^ cells secrete cytokines such as TNF-α and IFN-γ which help to eliminate virus-infected cells (Adapted from [@B17]).](fmicb-11-01756-g002){#F2}

Currently, several strategies are being employed in combating PRRSV, including manipulating the antiviral roles of host microRNAs, miRNAs (miRNA-181) small interfering RNAs (siRNAs), short-hairpin RNAs (shRNAs), artificial microRNAs, and PMOs (morpholino oligomers) and vaccines. All these have been tested for their ability to inhibit PRRSV infection both *in vitro* and *in vivo* ([@B33]). Herein we reviewed the current information on the various antiviral mechanisms of some selected TCMs against PRRSV infection. They were classified into two major groups based on their mode of actions, including those that directly inactivate the virus by targeting a specific step in the PRRSV life cycle (Direct Acting Antivirals), such as PRRSV entry blockers, viral replication inhibitors, assembly, packaging and progeny release inhibitors and those that indirectly inhibit the growth of the virus (Indirect-Acting Antivirals) by promoting the response of the immune system against PRRSV invasion through the regulation of cytokine synthesis ([@B16]). This group of TCMs act as immunomodulators and inhibitors of metabolic pathways that promote PRRSV pathogenesis.

Viral Propagation and Replication {#S1.SS2}
---------------------------------

Functionally, a virus exists in two unique forms; firstly, as a virion, which is the static, inactive extracellular form, devoid of any metabolic activity, but serves as the carrier of the viral genetic makeup and secondly, as an uncoated dynamic intracellular form, consisting of the full viral genetic material itself. Virus propagation involves the growth and multiplication of viruses through the synthesis of the viral genetic materials and release of the mature virion from infected host cells (*in vivo*) or media (*in vitro*) to new host or media ([@B40]). Virus replication, on the other hand, is the synthesis of complementary negative-sense RNA, which then serves as a template for positive-sense (genome-sense) RNA synthesis ([@B95]). Thus, to propagate itself, a virus has to enter a living cell and after that, release its genome from its capsid, and interacts with the host cell to replicate and produce viral proteins. New capsids are assembled, the newly synthesized genomes are then packaged into these capsids either concomitantly with or after their assembly. This results in progeny virions, which are released from the cell and transferred to new host cells. They achieve this by hijacking the biochemistry and metabolic pathways of the host cell to produce multiple copies of themselves and thus continue to infect new hosts.

Life Cycle of PRRSV {#S1.SS3}
-------------------

Viral entry and uncoating trigger the commencement of the life cycle, which encompasses genome translation and replication, leading to the assembly and release of infectious viral progeny. The entire life cycle begins with the translation of the large replicase gene. This replicase gene consists of two large open reading frames (ORFs) that are connected by a ribosomal frameshift site leading to an ORF1a encoded polypeptide (pp1a), and an ORF1a and 1b encoded polypeptide (pp1ab). This phase is followed by the translation of both pp1a and pp1ab polyproteins and then extensive autoproteolytic processing which leads to the synthesis of at least about 13 non-structural proteins ([@B115]). Upon proteolytic processing, the non-structural proteins become associated with intracellular membranes to form the replication/transcription complex (RTC) that is responsible for the synthesis of viral RNA. It comprises of the synthesis of the nested set of mRNAs and replication of the viral genomic RNA. RTC makes use of endoplasmic reticulum (ER) membranes to induce the formation of double-membrane vesicles (DMV) which establishes the RTC ([@B39]). A full-length negative-strand RNA (also called antigenome) is then synthesized by the RNA-dependent RNA polymerase (RdRp) which it uses as the template for the synthesis of new genomic RNA. In addition to its replication, the PRRSV genome also functions as a template for synthesizing sub genomic (sg) mRNAs generated from negative-strand intermediates. The transcripts of sg help to express the seven structural proteins of PRRSV. The translation of the structural proteins which takes place on ribosomes of the ER is followed by the phosphorylation of the N protein and the formation of homodimers that enclose the newly synthesized full-length genomes ([@B167]; [@B168]). In the ER, the major glycoprotein; GP5 and the minor glycoproteins GP2, GP3 and GP4 are glycosylated.

At the same time, the major envelope proteins form an M-GP5 complex heterodimer via an intermolecular disulfide bridge by engaging the cysteine residues in the ectodomains of both proteins ([@B98]), while the minor envelope proteins GP2, GP3, and GP4 form a heterotrimer complex in the PRRSV envelope ([@B164]) in a non-covalent union of GP2:GP4: GP3 in a 1:1:1 ratio. When all structural components are located at the same site of the ER, the nucleocapsid moves around the membrane, and budding eventually takes place in the lumen of the ER. The newly formed miniature virions move through the Golgi apparatus, and the process of maturation takes place via trimming of the core high-mannose glycan residues on the glycoproteins, and they are replaced with complex sugars. The GP2-GP4 heterodimer may become covalently attached to GP3 via disulfide linkages in the Golgi apparatus, as in the case of EAV. The newly synthesized PRRSV virions are finally released into the extracellular space via exocytosis ([@B8]; [@B39]; [@B149]), see [Figure 3](#F3){ref-type="fig"}.

![The Replication life cycle of PRRSV (adapted from [@B39] and [@B148]).](fmicb-11-01756-g003){#F3}

Traditional Chinese Medicines (TCM) {#S2}
===================================

Traditional Chinese Medicines have proven to be a valuable source of therapeutic herbs in China and other parts of the world. They elicit multiple biological activities such as antiviral, antibacterial, anti-inflammatory and antioxidant ([@B20]), for example, the TCM "Shuanghuanglian" has been used as an antiviral and antibiotic drug to treat respiratory-related diseases in China since 1973 ([@B180]), its chemical components include chlorogenic acid, baicalin, and forsythia glycosides ([@B180]); "Artemisinin" has been famous for its anti-malaria activity since 1979 ([@B145]). The discoverer Youyou Tu was awarded the Nobel Prize for Physiology or Medicine in 2015 ([@B136]). This gave more credence to the efficacy of TCM as a significant source of potential alternative therapy against diseases. Investigations from previous and on-going researches based on advanced molecular and analytical techniques have led to the extraction, quantification and classification of most of the bioactive compounds in TCM, including several classes of glycosides, terpenoids, coumarins, isoflavones, alkaloids, flavones, phenolic acids, lignans, lignins, tannins, carotenoids, polyacetylenes, asiatic acid, madecassoside, madecassic acid, asiaticoside, polyacetylene, among others. These compounds have various antiviral and immune-modulatory effects ([@B35]; [@B50]).

Some TCMs have been reported to have potent antiviral activities against PRRSV based on different antiviral strategies ([@B157]; [@B94]; [@B175]; [@B137]; [@B50]), including those with direct virucidal/antiviral mechanisms (Direct acting antivirals) and those that inhibit the proliferation of the virus by an indirect mode of action through the tweaking of the host innate immune system (Indirect acting antivirals).

Direct-Acting Antivirals (DAAs) {#S3}
===============================

Direct-acting antivirals (DAAs) are drugs that target specific steps in the life cycle of a virus and thus alters the viral genome and proteins ([@B6]; [@B56]). Although, just like the Indirect acting antivirals, DAA is a term for drugs designed for the treatment of HCV infection ([@B146]; [@B12]; [@B5]; [@B27]), however, in this review, TCMs with antiviral strategies that target specific steps in the life cycle of PRRSV have been classified under this group. They include PRRSV entry blockers, replication inhibitors, and PRRSV packaging, assembly and viral particles release inhibitors.

PRRSV Entry Blockers {#S3.SS1}
--------------------

As an enveloped virus, PRRSV enters into PAMs through a pH-dependent (low pH) membrane-bound, receptor-mediated endocytosis ([@B71]; [@B77]; [@B73]; [@B125]; [@B127]). Several bioactive compounds extracted from Chinese herbs exhibit antagonistic activities toward PRRSV, or prevent the viruses from attaching to putative receptors, or block their entrance into cells *in vitro* by interfering with the process that leads to the uncoating of the viral genome ([Figure 3](#F3){ref-type="fig"}). These happen either by (i) bioactive compound - viral interaction, (ii) increasing the pH level of the endocytic pathways, or (iii) by modulating the expression of putative receptors. Some of these mechanisms are outlined below.

Interaction With the Receptor to Interfere With Viral Attachment {#S3.SS2}
----------------------------------------------------------------

Viral attachment and entry into host cells is the first stage of the viral life cycle. PRRSV infection is dependent on various cellular receptors or factors ([@B33]). Numerous studies have demonstrated that PRRSV entry blockers are a promising novel approach to combat PRRSV infection, these blockers include antibodies from vaccines, some chemical reagents and some TCMs ([@B33]). (--)-Epigallocatechin-3-gallate (EGCG) is the most abundant bioactive compound in Green tea ([@B42]; [@B18]; [@B135]), it has been reported to inhibit PRRSV replication in MARC-145 cells *in vitro* based on the following multiple mechanisms: (i) it prevented the attachment of PRRSV to susceptible cells by downregulating the expression of PRRSV receptors CD163, MYH9, and HS in EGCG pre-treated cells in a dose-time dependent manner; (ii) it acted directly on the visions as an antiviral receptor mimetic which competes with both heparin and sialic acid moieties for virion binding by attaching to the active site of the PRRSV glycoprotein (GP5) ([@B26]; [@B50]).

Interaction With Cellular Membrane to Inhibit Cellular Penetration by PRRSV Particles {#S3.SS3}
-------------------------------------------------------------------------------------

Viral proliferation can be inhibited by interfering with the cellular membranes of host cells. Several studies have revealed that some TCM can interact with the cellular membranes of macrophages thereby inhibiting cellular penetration by viral particles, notable among these viruses include HBV ([@B129]), HCV ([@B101]), HSV ([@B59]), SARS coronavirus ([@B25]), and influenza viruses ([@B165]). Glycyrrhizin (GL), a triterpene saponin found in abundant quantity in licorice root (*Glycyrrhiza glabra*), which has been reported to be an active antiviral bioactive compound against the various stages of the life cycle of PRRSV *in vitro*. The postulated antiviral mechanisms of GL include direct effects on the adsorption, penetration and particle maturation steps of PRRSV reproductive cycle. It was reported that PRRSV-infected MARC-145 cells treated with GL during the penetration phase of the viral life cycle showed a significant reduction in PRRSV particles observed at this stage of the viral life cycle. This demonstrated that GL inhibited PRRSV internalization into MARC-145 cells ([@B35]). Besides, earlier studies had revealed that GL inhibits virus penetration by modifying the viscosity of the phospholipid content of the lipid bilayer of viral cell membranes. PRRSV enters into MARC-145 cells through a microfilament-dependent endocytic pathway ([@B77]). It was, therefore, inferred that GL might most likely inhibit the penetration of PRRSV by interfering with the cellular membrane and eventually lead to a reduction in endocytosis ([@B35]). However, further studies will be needed to verify this claim.

Inhibition of Virus Internalization and Cell Fusion {#S3.SS4}
---------------------------------------------------

An enveloped virus fuses its membrane with a host cell membrane, thereby releasing its genome into the cytoplasm and initiating the viral replication cycle. Some TCM stops the replication cycle of viruses by preventing virus internalization and virus-mediated cell fusion. After internalization, the viral particles are transported to the endosome. The acidic condition in the endocytic pathway causes changes in the conformation of the viral membrane and glycoproteins, which result in the uncoating of virus particles, thereby causing infection.

For PRRSV, the process can be inhibited by curcumin due to the inhibition of PRRSV membrane fusion, N protein and viral progeny production in MARC-145 and PAM cells ([@B34]). Curcumin, also known as diferuloylmethane, is a natural bioactive compound isolated from the rhizomes of *Curcuma longa* ([@B34]). Curcumin belongs to the polyphenol group of organic compounds and has multiple functions including its antiviral ability ([@B153]; [@B154]; [@B7]; [@B96]; [@B2]; [@B72]; [@B123]; [@B105]; [@B100]; [@B119]). In a study involving the treatment of infected MARC-145 and PAM with Curcumin, curcumin significantly inhibited the entry of PRRSV into the cells by interfering with all the post-internalization stages of PRRSV, which blocked viral membrane fusion and stopped the uncoating of the PRRSV genome in MARC-145 and PAM cells ([@B34]).

Tetrahydroaltersolanol C (TD-C) was also reported to inhibit the internalization stage of PRRSV. TD-C is a hydroanthraquinone extracted from *Alternaria* sp., a fungus obtained from *Sarcophyton* sp. (a soft coral found in tropical and subtropical seas) ([@B48]; [@B184]). TD-C significantly inhibited the proliferation of PRRSV when cells were pre-incubated or co-incubated with it; the significant inhibition of the yield of viruses proved that it might effectively interfere with viral internalization and cause a significant reduction in the viral progeny titers. TD-C significantly exhibited antiviral activity against PRRSV during viral internalization and replication stages. The mechanism of action could be attributed to the direct inhibition of growth, adsorption, fusion, internalization, and replication of PRRSV, which are all critical stages of the life cycle of the virus ([@B79]; [@B48]). However, the specific mode of action of TD-C against PRRSV still needs further investigation.

Prevention of PRRSV Internalization Through Viral Particles Agglutination {#S3.SS5}
-------------------------------------------------------------------------

The entry phase of PRRSV is made up of early viral attachment and internalization ([@B46]). Just like other enveloped viruses, PRRSV infects cells after attachment to a cellular receptor, and it is internalized from the surface of susceptible cells within 3--6 h ([@B46]). *Cryptoporus volvatus* (Pk.) Hubbard is a polypore fungus that belongs to the family Polyporaceae. Aqueous extracts of *C. volvatus* inhibited PRRSV internalization but not its attachment to the host cells by causing the viral particles to agglutinate and form clusters outside the cell membrane ([@B46]). Other secondary effects, including the inhibition of PRRSV protein synthesis, infectious PRRSV particle release and the cell-to-cell spread of the virus were reported due to the inhibition of PRRSV entry and RNA polymerase activity. The aqueous extract obtained from *C. volvatus* consist of numbers of bioactive components and the exalt active ingredient responsible for its antiviral activity is under investigation.

Besides, the presence of PRRSV in host cells can be inhibited through multiple mechanisms, for example, aromatic plants, such as *Thymus vulgaris* which is rich in essential oils and lipophilic substances ([@B113]), and *Nepeta cataria, whose* bioactive compounds include monoterpenes, sesquiterpenes, diterpenes, triterpenes, flavonoids, phenol, essential oils, and others ([@B1]); can both significantly reduce PRRSV amount at the pre-entry and post-entry steps of the viral life cycle by blocking viral attachment, adsorption, replication, and release ([@B67]). A summary of the PRRSV entry blockers described above is presented in [Table 1](#T1){ref-type="table"}.

###### 

A summary of PRRSV entry blockers.

  TCM                                      Compounds                                Antiviral Strategy                                                     Mechanism                                                                                                                                         References
  ---------------------------------------- ---------------------------------------- ---------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------- ------------
  Green Tea (*Camellia sinensis*)          -(-) epigallocatechin-3-gallate (EGCG)   Inhibits viral attachment and penetration                              Down-regulate the expression of PRRSV receptors Acts as a receptor mimetic by binding to viral glycoprotein and interfere with viral attachment   [@B50]
  Licorice roots (*Glycyrrhiza glabra*).   Glycyrrhizin (GL)                        Inhibits viral penetration and internalization                         Modifies the viscosity of the phospholipid content of the lipid bilayer of viral cell membranes                                                   [@B35]
  *Thymus vulgaris*                        *Thymus vulgaris* hydrosol               Blocks pre-entry and post-entry stages of PRRSV                        Binds to PRRSV receptors, interferes with viral envelope and masks viral components                                                               [@B67]
  *Nepeta cataria*                         *Nepeta cataria* hydrosol                Blocks pre-entry and post-entry stages of PRRSV                        Blocks viral attachment and adsorption                                                                                                            [@B67]
  Turmeric rhizomes *(Curcuma longa)*      Curcumin                                 Blocks viral membrane fusion and stops the uncoating of PRRSV genome   Prevents virus internalization and virus-mediated cell fusion by preventing the reduction in cellular pH level                                    [@B34]
  Tea Seed                                 Tea Seed Saponins (TS)                   Blocks PRRSV entry and inhibits viral replication                      Direct inactivation of virus                                                                                                                      [@B85]
  *Cryptoporus volvatus* (Pk.) Hubbard     *Cryptoporus volvatus* extract           Inhibit PRRSV internalization but not attachment to the host cells     Inhibits PRRSV RNA-dependent RNA polymerase (*RdRp*)                                                                                              [@B46]
  *Alternaria* sp. (Fungus)                Tetrahydroaltersolanol C (TD-C)          Interferes with viral internalization                                  Direct inhibition of growth, adsorption, fusion, internalization and replication                                                                  [@B184]

PRRSV Replication Inhibitors {#S3.SS6}
----------------------------

The replication stage is the most significant phase in the life cycle of a virus. It starts by the translation of the large replicase gene and through a series of synthetic pathways culminate in the viral particles' synthesis and release. Inhibitors of viral proteases, polymerases, integrases (helicases), reverse transcriptase and heparanase of several viruses have been successfully investigated, including the inhibition of different viral stages in *in vitro* and clinical trials ([@B88]).

Inhibition of the Early Stage of PRRSV Replication Through Viral Inactivation {#S3.SS7}
-----------------------------------------------------------------------------

Host cells are usually less susceptible to inactivated viruses, and the process includes solvent/detergent, low pH, and heat treatments ([@B128]). Chlorogenic acid is a vital plant polyphenol derived from coffee. It is an ester of caffeic acid ([@B144]; [@B23]). Chlorogenic acid has a strong anti-PRRSV effect *in vitro* ([@B162]).

Similar results were observed in Scutellarin-treated cells infected with PRRSV. Scutellarin is a flavone glucuronide derived from *Scutellaria barbata* and *Scutellaria lateriflora*. Its pharmacological actions include anti-inflammation and viral inhibition. They inhibited the replication of PRRSV by directly inactivating PRRSV *in vitro* [@B23]). A similar effect was also observed in infected Marc-145 cells treated with chlorogenic acid and scutellarin at different time intervals ([@B23]).

*Cynodon dactylon* is a common perennial native grass that grows naturally in the tropics and warm temperate regions. It is also known as Bermuda grass and belongs to the family Poaceae. The extracts of *C. dactylon* are known for their antimicrobial, anti-diabetic, anti-hyperlipidemia, anti-inflammatory, antiemetic and cardioprotective activities ([@B131]; [@B47]; [@B61]). A virustatic and virucidal study was conducted to investigate its effect on the replication stage of PRRSV; the results demonstrated that its ethanol extracts had both virustatic and virucidal effects on the replication stage of PRRSV. It significantly inhibited the replication of the virus in a dose-dependent manner. IPMA also revealed that the same concentration of ethanol extracts of *C. dactylon* significantly inactivated the already released virions ([@B121]).

Inhibition of N Gene Expression and N-Proteins Synthesis {#S3.SS8}
--------------------------------------------------------

As the most abundant viral structural protein, PRRSV nucleocapsid (N) protein form the viral capsid by interacting with itself through covalent and non-covalent interactions to package the viral genome ([@B91]). Inhibition of N gene expression or N-proteins synthesis interferes with PRRSV replication. This occurs by down-regulating the N gene expression both at the mRNA stage and protein level. The expression of N-Protein leads to the expression of TNF-α, a proinflammatory cytokine and the activation of NF-κB pathway with a concomitant up-regulation of Interleukin-10 (IL-10) in PAMs ([@B166]; [@B134]). IL-10 is pleiotropic, and it is produced by many types of cells, including monocytes/macrophages, cells that play a critical role in the inflammatory process ([@B108]). The up-regulation of IL-10 inhibits expression of N-Protein, prevents TNF-α-induced apoptosis by downregulating IKK phosphorylation and in turn, NF-κB activation ([@B29]). Sodium tanshinone IIA sulfonate (STS) is a bioactive compound derived from *Salvia miltiorrhiza* ([@B139]). The anti-PRRSV activity mechanism of STS involves two pathways: firstly, it inhibits the transcription and translocation of N-protein, and thereby reduce the N protein-induced host cell apoptosis ([@B137]); secondly, STS inactivates PRRSV directly.

Findings from RT-PCR, western blot and indirect immunofluorescence assays revealed that the biological activity of STS is dose-dependent.

Flavaspidic acid AB (FA-AB) was also observed to inhibit the replication stage of PRRSV by inhibiting the synthesis of N-proteins in FA-AB treated PAM cells ([@B175]). FA-AB belongs to the family of phloroglucinol according to its chemical structure, which is isolated from *Dryopteris crassirhizoma* Nakai (a semi-evergreen fern) and possesses anti-oxidant, anti-bacterial and anti-tumor ([@B69]; [@B99]; [@B81]; [@B54]; [@B155]). [@B175] reported that FA-AB partially inhibited the entry stage of PRRSV, blocks the cell-to-cell transmission pathway which is typical of PRRSV and caused a reduction of virus titers in cells by inhibiting the synthesis of N-proteins in a dose and time-dependent manner.

Zn^2+^ From Natural Zinc Ionophore Inhibits PRRSV Replication by Decreasing the Transcription and Translation Levels of PRRSV N Protein {#S3.SS9}
---------------------------------------------------------------------------------------------------------------------------------------

Pyrithione is a common organosulfur compound with molecular formula C~5~H~5~NOS. Pyrithione is the short form of pyridinethione. This compound is a natural zinc ionophore, and it functions as a centrosymmetric dimmer to increase intracellular Zn^2+^ concentration via its oxygen and sulfur centers ([@B122]). It is found in Persian shallot-an Asian species of onion native to central and southwestern Asia ([@B37]). It exists naturally as a pair of tautomers. The major and minor forms are thione 1-hydroxy-2(1H)-pyridinethione and thiol 2-mercaptopyridine N-oxide, respectively. Zinc ions are involved in many critical cellular processes. They play a significant role in the proper folding and activity of various cellular enzymes and transcription factors. Keeping the available Zn^2+^ concentration in cells at a stable homeostatic equilibrium is very vital for cell survival because any change above or below the normal threshold levels can trigger apoptosis in a variety of cell types ([@B152]). It is also an essential cofactor for numerous viral proteins ([@B122]). A mechanistic study has shown that PT has potent antiviral activity against the replication stage of the life cycle of PRRSV and other several RNA viruses ([@B53]). It does this by effectively decreasing the transcription and translation levels of the PRRSV N protein with the help of the imported extracellular Zn^2+^.

Inhibition of the Post Entry Stage of PRRSV Replication by Inhibiting the N-Protein Synthesis and P13K/Akt and ERK Signaling Pathways {#S3.SS10}
-------------------------------------------------------------------------------------------------------------------------------------

Porcine reproductive and respiratory syndrome virus RNA replication begins at the post-entry stage of viral replication, an antiviral strategy based on inhibition of the post-entry stage of PRRSV replication has also been reported ([@B184]). Isobavachalcone (IBC) is one of the prenylated chalcones derived from *Psoralea corylifolia* ([@B78]); it belongs to the subclass of flavonoids and has a broad-spectrum biological activity against bacteria and fungi, and as well acts as an anti-reverse transcriptase, anti-tubercular and antioxidant ([@B78]). Marc145 cells were infected with PRRSV and then treated with IBC at specific time points (2, 6, 12, or 24 h), the levels of PRRSV replication were inhibited from 2 to 6 hpi, demonstrating that IBC blocks the early stages of the viral life cycle, most likely at the initiation of viral RNA replication. Further verification using IBC treated PAMs cells showed that the dsRNA levels were significantly reduced ([@B156]).

Extracts from *Sasa quelpaertensis* Nakai, (*Jeju-Joritdae*) leaves (SQE), a dwarf type of bamboo grass that is widely distributed on Mt. Halla in Jeju Island, South Korea have also been reported to show potent biological activities against PRRSV. It was observed that SQE significantly inhibited the post-entry stages during the replication of PRRSV in treated cells. This was demonstrated by reduced progeny production and inhibition of viral protein expression. The anti-PRRSV strategy of SQE is based on its ability to inhibit the synthesis of genomic RNA and sg mRNA ([@B68]).

Regulation of Viral ORF1 Function {#S3.SS11}
---------------------------------

Porcine reproductive and respiratory syndrome virus ORF1 encodes 14 non-structural proteins, which include four proteases (NSP1, NSP1, NSP2, and NSP4), the RNA-dependent RNA polymerase (NSP9), a helicase (NSP10) and an endonuclease (NSP11) ([@B13]; [@B133]; [@B188]; [@B147]). Dipotassium glycerrhetate (DG) is a derivative of glycyrrehetinic acid (GA) extracted from the roots of Licorice (*Glycyrrhiza glabra*), it inhibits the replication of PRRSV by regulating the function of the viral ORF1 and concomitantly inhibiting the synthesis of RNA-dependent RNA polymerase (RdRp) ([@B163]). DG protected cells against PRRSV induced apoptosis through the inhibition of Caspase-3 protein degradation system after been used to treat infected cell ([@B163]).

Inhibition of Viral Nsp9-p107 Interaction {#S3.SS12}
-----------------------------------------

The Nsp9 of PRRSV contains the viral replicase RNA-dependent RNA polymerases (RdRp), it plays a critical role in the replication of the virus ([@B82]; [@B140]). The SDD (Serine-Aspartic Acid-Aspartic acid) motif, located at residues 3050--3052 of Nsp9, has been reported to be vital for its polymerase activity and virus replication ([@B187]). Some researchers have reported that a host of proteins interact with Nsp9 and influence the replication of the virus ([@B32]; [@B87]; [@B185]). PRRSV could be inhibited by specific siRNA targeting Nsp9 gene ([@B170]). [@B140] used the dual-luciferase reporter assay to detect the interaction between Nsp9 and the E2F reaction promoter p107, and the results indicated that Nsp9 could activate the promoter p107, and consequently aid cells to enter the S phase, this enhances the replication of the virus. Chinese traditional herbal medicine, matrine, an alkaloid that is extracted from *Sophora flavescens Ait*, is an essential herb with a lot of biological activities ([@B138]; [@B179]; [@B169]). It inactivates PRRSV by direct interaction with the virus, leading to the inhibition of the replication stage of the viral life cycle ([@B138]). The effects of matrine on the mRNA expression of PRRSV N gene and the protein expression of pERK1/2 and PRRSV Nsp9 activity was investigated; it was observed that matrine inhibited the interaction between Nsp9 and promoter p107. PRRSV Nsp9 binds to promoter p107 for PRRSV RNA synthesis. Thus, the inhibition of the Nsp9-p107 interaction leads to the termination of the synthesis of PRRSV RNA and related proteins in host cells ([@B140]), suggesting that the mechanism by which matrine inhibited the replication of PRRSV is independent of the entry process of PRRSV, as well as ERK1/2 signal pathway.

Inhibition of PRRSV Replication by Interfering With RNA-Dependent RNA Polymerase (RdRp) Activity {#S3.SS13}
------------------------------------------------------------------------------------------------

The formation of RNA-template or RNA synthesis catalyzed by viral RNA-dependent RNA polymerase (RdRp) is required to replicate and transcribe the viral genome ([@B70]). Inhibitors targeting the viral RdRp were developed as another antiviral strategy to inhibit the replication of positive-strand RNA viruses ([@B143]; [@B49]), for example, several structural classes of non-nucleoside inhibitors (NNIs) can inhibit the non-structural protein 5B RNA-dependent RNA polymerase (NS5B RdRp) of HCV by binding to the protein surface in the narrow cleft in the thumb domain blocking the RdRp activity before the formation of an elongation complex and therefore efficiently block the replication of HCV subgenomic replicons in tissue culture ([@B143]; [@B157]; [@B90]; [@B117]; [@B10]). Nanomolar inhibitors consisting of a class of acyl sulfonamide-thiophene compounds with nanomolar inhibitory effects against the *de novo* initiation activities of DENV1-4 RdRp has also been developed ([@B89]). This same strategy is currently being explored in combating the current global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ([@B51], [@B52]; [@B178]). Investigation by [@B46] revealed that aqueous extracts from *C. volvatus* the inhibited the replication of PRRSV by targeting and interfering with the activity of viral RdRp. *In vivo* study also revealed that aqueous extracts from *Cryptoporus volvatus* (Pk.) Hubbard inhibited the replication of the highly pathogenic PRRSV (HP-PRRSV) in pigs ([@B46]). [Table 2](#T2){ref-type="table"} summarizes this group of compounds and their antiviral strategies.

###### 

A summary of PRRSV replication blockers.

  TCMs                                           Compounds                         Antiviral strategy                                                          Mechanism                                                                                                                                                       References
  ---------------------------------------------- --------------------------------- --------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------
  *Scutellaria barbata*, *S. lateriflora*        Scutellarin                       Inactivates and/or interferes with the early stage of PRRSV replication     Direct inactivation of PRRSV (Virucidal effect)                                                                                                                 [@B23]
  Rhizomes of *Dryopteris crassirhizoma* Nakai   Flavaspidic Acid Ab (Fa-Ab)       Partially inhibits viral entry and significantly Blocks viral replication   Blocks cell-cell spreading Inhibits the synthesis of N-proteins                                                                                                 [@B175]
  Coffee                                         Chlorogenic acid                  Inhibits early stage of the PRRSV replication cycle                         Direct inactivation of PRRSV (Virucidal effect)                                                                                                                 [@B23]
  *Cynodon dactylon*                             *Cynodon dactylon* extracts       Inhibits PRRSV replication cycle                                            Virustatic and virucidal effects on the replication stage of PRRSV                                                                                              [@B121]
  *Psoralea corylifolia*                         Isobavachalcone (IBC)             Inhibits the Post entry stage of PRRSV replication                          Reduces PRRSV N-protein                                                                                                                                         [@B156]
  *Salvia miltiorrhiza*                          Sodium tanshinone IIA Sulfonate   Inhibits PRRSV replication                                                  Inactivates or disrupts the replication pathway of the PRRSV Down-regulates N gene expression and inhibits the transcription, and translocation of N-protein.   [@B137]
  Licorice roots (*Glycyrrhiza glabra*).         Dipotassium Glycerrhetate (DG)    Inhibits the replication of PRRSV                                           It suppresses the function of ORF1                                                                                                                              [@B163]
  *Persian shallot*                              Pyrithione                        Inhibits PRRSV replication                                                  Decreases the transcription and translation levels of the PRRSV N protein with the help of imported extracellular Zn^2+^                                        [@B53]
  *Sasa quelpaertensis* Nakai                    *Sasa quelpaertensis* (SQE)       Inhibits the post-entry steps during the replication of PRRSV               Progeny reduction, diminished viral protein expression, and reduced synthesis of genomic RNA, and sg mRNA                                                       [@B68]
  *Sophora flavescens Ait*                       Matrine                           Inhibits the replication of PRRSV                                           Inhibits the interaction between Nsp9, and promoter p107                                                                                                        [@B141]

PRRSV Packaging, Assembly and Release Inhibitors {#S3.SS14}
------------------------------------------------

Porcine reproductive and respiratory syndrome virus package and assembly stage starts after 8 h-post infection (hpi). This is the last stage of the viral life cycle. During this stage, the newly synthesized viral genomes are packaged into capsids for intracellular transport, enveloped and then finally released into the extracellular space via exocytosis ([@B118]; [@B132]; [@B111]; [@B35]; [@B70]; [@B53]). Available evidence has proved that bioactive compounds from some TCMs interfere with the packaging, assembly, and release of PRRSV particles. More investigations are needed to confirm this claim further.

Inhibition of PRRSV Progeny Release by Regulating the Expression of Cytokines {#S3.SS15}
-----------------------------------------------------------------------------

The initial primary defense response of animals to viral infection is the production of Interferon-alpha (IFN-α) (a type 1 interferon), often followed by inflammatory cytokines such as tumor necrosis factor (TNF) and interleukin-1 (IL-1). However, with PRRSV infection, such response is weakened or significantly suppressed. Several reporters have stated that the expression of interferon --α inhibits the replication of PRRSV *in vitro* ([@B15], [@B14]). The expression of inflammatory cytokine plays a very significant role in the organization of the host immune system against a variety of viral infection ([@B9]). TNF, IL-1β, and IL-6 are important activators of the nuclear transcription factor, NF-κB ([@B31]; [@B24]). The function of NF-κB during infection is to regulate the transcription of hundreds of genes, including antigen receptors, inflammatory and immunoregulatory cytokines, adhesion molecules, inhibitors of apoptosis, acute phase proteins, and innate effector molecules. It was speculated that the mild or subclinical respiratory abnormalities involved in PRRSV infection might be due to the lack of activation of NF-κB. However, when there is a lack of an acute inflammatory response and weak innate antiviral activity, the resultant effect might also be an incomplete stimulation of antigen-specific immune responses, and this will promote the establishment of persistent infection ([@B150]). *Platycodon grandiflorum* A. DC (Campanulaceae) is a well-known Chinese herb. The root of this herb is a significant source of saponins ([@B172]; [@B181]), it is used as an expectorant for pulmonary diseases and a therapy for respiratory disorders ([@B83]). Among the Saponins present in *Platycodon grandiflorum* A. DC, is Platycodin D (PD), an oleanane-type triterpenoid saponin with two sugar chains attached to positions C-3 and C-28 of aglycone. It is regarded as the most biologically potent among *platycodin saponins* ([@B171]). PD impaired the entry and replication of PRRSV in MARC-145 cells in a dose-dependent manner. A significant decrease in the number of viral progenies was observed both in MARC-145 cells and PAMs ([@B181]) in treated infected cells.

Platycodin D treatment significantly inhibited the expression of six cytokines, including IFN-α IFN-β, IL-1α, IL-6, IL-8, and TNF-α in a time-dependent manner in infected cells ([@B181]). Interestingly, it is worthy to note that PD also enhanced TNF-α expression in un-infected PAMs indicating that PD has a dual antiviral activity by increasing the expression of TNF-α in uninfected cells thereby enhancing or fortifying the innate immune system of cells against invading PRRSV from neighboring cells, on the one hand, and concomitantly, reduces the high expression of TNF-α in infected cells, on the other hand, thereby helping the infected cells to attenuate TNF-α induced apoptosis. This pleiotropic property of PD might be indirectly responsible for the inhibition of PRRSV progeny release in PD treated cells ([@B181]).

Deactivation of NF-κB/Heparanase Pathway {#S3.SS16}
----------------------------------------

Heparan sulfate is an integral part of the extracellular matrix (ECM); it enhances the initial attachment of viruses to target cells. Heparanase is the only enzyme that can degrade HS and thus, promote the release of HS-bound viruses, cytokines and other related proteins such as growth factors in many biochemical paradigms ([@B177]). As a receptor of PRRSV, HS bind to PRRSV, thus a decrease in the availability of HS at surfaces of cells encourage PRRSV exit. Studies have revealed that heparanase is upregulated through the activation of NF-κB pathway (by TNF, IL-1β, IL-6, and other vital activators) when cells are infected by viruses, which is then translocated to the cell surface, leading to the decreased HS expression. This permits the release of exiting viral particles ([@B55]).

Pyrithione (PT) is a broad-spectrum antimicrobial compound. By the same biochemical mechanism with which it inhibited the replication of PRRSV, it also concomitantly stopped the packaging, assembly, and release of the viral particles via multiple pathways. By interfering with NF-κB activation, PT inhibited the expression of heparanase and then blocked the loss of HS from the cell surface, thereby, stopping the release of virus and cytokines ([@B53]). The expression of heparanase is increased in PRRSV infected cells; this resulted in a remarkable decrease in the level of HS during the later stage of PRRSV infection. And interestingly, treatment with PT caused a significant increase in the level of HS present on the surface of PRRSV infected cells. The increased level of HS led to a significant decrease in the number of viral progeny released ([@B53]). See the summary of PRRSV packaging and assembly inhibitors in [Table 3](#T3){ref-type="table"}.

###### 

A summary of PRRSV packaging and assembly inhibitors.

  TCMs                              Compounds                   Antiviral Strategy                                                                                                   Mechanism                                                                                                                                                                                                                                                         References
  --------------------------------- --------------------------- -------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------
  *Platycodon grandiflorum* A. DC   Platycodin D (PD)           Multiple strategies: Blocks viral entry and internalization, inhibits viral replication, and stopped viral release   Binds to one of the PRRSV surface molecules (E and GP2 to GP5) Inhibits PRRSV NSP9 RNA levels, and N protein in a dose dependent manner Enhances TNF-α expression                                                                                                 [@B181]
  Grape seed *Vitis vinifera*       Proanthocyanidin A2 (PA2)   Multiple Strategies: Blocks viral attachment, internalization, viral packaging, and progeny release                  Direct PRRSV inactivation or impairment. Inhibits PRRSV NSP9 RNA expression in a dose dependent manner Inhibits the expression of PRRSV -- induced pro-inflammatory cytokines Inhibits the release of PRRSV progeny particles by deactivating the NF-κB pathway   [@B182]
  *Persian shallot*                 Pyrithione                  Stopped the packaging, assembly, and release of the viral particles via multiple pathways                            Interferes with NF-κB activation Inhibits the expression of heparanase, and then blocked the loss of HS from the cell surface                                                                                                                                     [@B53]

Indirect Acting Antivirals (IAAs) {#S4}
=================================

These group of antivirals inhibit the growth of viruses through the modification of the host immune system. They inactivate viral genomes and proteins through the regulation of cytokine synthesis, lipid metabolism and immune cells activation ([@B16]) and thus, abrogate the pathways hijacked by viruses to perpetuate infection ([@B6]) without compromising the host cell metabolism. Categorized under this group are TCMs that inactivate PRRSV genome and proteins by modulating the host immune system and deactivating metabolic pathways that promote PRRSV pathogenicity ([@B182]).

Immunomodulators and PRRSV Pathogenic Pathways Inhibitors {#S4.SS1}
---------------------------------------------------------

The first line of the host defense against viral infections is the innate immune system; it consists of a network of barriers, including physical barriers, i.e., the skin and mucous membranes; chemical barriers, i.e., antimicrobial peptides, pH, lipids, enzymes, as well as immune cells, i.e., monocytes, macrophages, eosinophils, neutrophils, and natural killer (NK) cells ([@B93]). The structural and functional integrity of the host immune system guarantees the initiation of an immune response against intracellular pathogens, prevent the replication of viruses in host cells and their invasion into mucosal tissues ([@B76]). PRRSV infection affects both innate and adaptive immune responses, i.e., delays and reduces the humoral and cell-mediated immune (CMI) responses, deregulates cytokines expression ([@B124]; [@B36]; [@B92]), and induces prolonged viremia and persistent infection in pigs ([@B106]). The immune-related functions of TCMs with anti-PRRSV effect are associated with their ability to regulate the production of cytokines in host cells ([@B16]) and deactivate pathways that promote PRSSV pathogenesis ([@B182]).

These soluble extracellular proteins or glycoproteins are essential regulators of biochemical processes that occur in the intercellular domains; they help to mobilize cells engaged in innate and adaptive inflammatory host defense mechanisms such as the regulation of NK cell function during viral infection which is regulated by IFNα, IFNβ, IL-12, and IL-15 ([@B112]), cell growth, differentiation, cell death, angiogenesis, as well as developmental and repair processes aimed at the restoration of homeostasis ([@B114]).

Th1 cytokines, IFN-γ and IL-12, play critical roles in fighting against viral infections ([@B124]). However, PRRSV infections induce significant suppression of the NK cell cytotoxic activity ([@B124]; [@B36]), leading to delayed and reduced humoral and cell-mediated immune responses due to the increased expression of the anti-inflammatory cytokine IL-10 and thus, suppresses the action of proinflammatory cytokines, such as TNF-α and IFN-γ ([@B92]). The following have been reported as the roles of TCMs in the modulation of cytokines and inhibition of PRRSV.

Promoting the Expression IFN-α {#S4.SS2}
------------------------------

Interferon alpha is a type I pleiotropic cytokine that directly participates in several critical host innate and adaptive immune responses. Its ability to promote the production of various potent antiviral mediators that hinder viral replication and packaging makes it very vital in the host defense system ([@B15]). Also, IFN-α enhances the ability of antigen-presenting cells to activate lymphocytes through the production of cytokines and expression of antigen-presentation molecules. Besides, IFN-α can work directly on T cells to drive maturation from a naïve T cell to an effector cell ([@B60]). IFN-α is primarily produced in response to a viral infection. Still, it is generally known that PRRSV does not induce a robust IFN-α response, which may secondarily affect the development of an adaptive immune response. Available evidence shows that IFN-α, either as a recombinant protein or through *in vivo* expression of the cloned gene, may enhance the host response to PRRSV, aiding in clearance and increased adaptive immunity ([@B15]).

*Forsythia suspense* Vahl (Oleaceae) is a widely known TCM herb. The fruit of *F. suspense* is known to contain Forsythoside A, an important bioactive compound with known biological activities against inflammation, pyrexia, sepsis, bacterial ([@B62], [@B63], [@B64]), and viral infections ([@B86]). It inhibited the replication cycle of PRRSV by significantly reducing the viral RNA copies at the intracellular level in a dose-dependent manner. The suggested mechanism of action is its ability to induce the production of IFN-α actively. This proinflammatory cytokine helps to boost innate immunity in infected MARC-145 cells ([@B174]).

TCM Impaired the Assembly PRRSV Progeny by Inducing Type 1 IFNs {#S4.SS3}
---------------------------------------------------------------

Dipotassium glycyrrhetate inhibited the proliferation of PRRSV N-protein infection by promoting the production of IFN-α, IFN-β, and IL-1β in PAMs This resulted in the loss of cellular functions in PRRSV and thus, inhibited the assembly of PRRSV progeny in treated cells ([@B163]).

Inhibition of Proinflammatory Cytokines {#S4.SS4}
---------------------------------------

Several authors have reported the anti-inflammatory effects of TCM through modulation of the expression of pro-inflammatory cytokines and chemokines ([@B110]; [@B58]) including TNF-α ([@B43]). A study by [@B50] showed that increased expression of mRNA transcripts encoding TNF-α, IL-6, and IL-8 after PRRSV infection was reversed by treatment with (--)-epigallocatechin-3-gallate (EGCG). However, treating PRRSV infected cells with EGCG could only suppress viral replication during the early stages of viral infection. The investigation of [@B182] confirmed that PRRSV infection induced significant RNA expression of three pro-inflammatory cytokines TNF-α, IL-1β, and IL-6, and a relatively small increase in the RNA expression level of IFN-α. It was also observed that the treatment of infected cells with proanthocyanidin A2 (PA2) significantly inhibited PRRSV-induced increase of RNA expression of TNF-α, IL-1β, and IL-6 in PAMs. This was in tandem with earlier reports ([@B3]). They observed that grape seed proanthocyanidin extracts protected mice against carrageenan-induced lung inflammation through the down-regulation of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, and IFN-γ) and chemokine MCP-1 and inhibition of infiltration of inflammatory cells to the damaged area. It was also reported that proanthocyanidin prevented lipopolysaccharide-induced depression-like behavior in mice through the neuroinflammatory pathway ([@B65]). They further observed that proanthocyanidin caused the inhibition of LPS-induced iNOS and COX-2 overexpression by modulating NF-κB pathway and thus inhibited the overexpression of pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6) in the hippocampus.

Deactivation of IL-1β Secretion and Inhibition of MyD88/NF-κB Signaling Pathway and NLRP3 Inflammasome {#S4.SS5}
------------------------------------------------------------------------------------------------------

Porcine reproductive and respiratory syndrome virus infection triggers the secretion of IL-1β, an essential proinflammatory cytokine synthesized mainly by macrophages, monocytes and dendritic cells that plays a critical role in coordinating the inflammatory and immune responses of the host system against invading pathogens ([@B38]). The up-regulation of IL-1β in PRRSV infected PAMs is mediated by the TLR4/MyD88 pathway and NLRP3 inflammasome ([@B11]). The expression of the TLR4/MyD88 signaling pathway activates the NF-κB pathway. The activation of the NF-κB pathway significantly increases the production of various proinflammatory cytokines, including IL-1β, IL-6, IL-8, and TNF-α, leading to increased pathogenesis and apoptosis. Matrine significantly inhibited the secretion of IL-1β and other proinflammatory cytokines by deactivating the synthesis of MyD88/NF-κB andNLRP3 inflammasome *in vitro* ([@B141]).

The investigation of Ge and co-workers showed that (--)-epigallocatechin-3-gallate (EGCG) significantly down-regulated proinflammatory cytokines TNF-α, IL-6, and IL-8. Besides, there is a remarkable increase in the production of cytokines including TNF-α, IL-6, and IL-8 especially during the early stage of PRRSV infection ([@B151]; [@B142]; [@B22]). Therefore, the down-regulation of these proinflammatory cytokines and chemokine by treatment with ECGC in PRRSV infected cells was because ECGC was found to reverse the increased expression of mRNA transcripts encoding TNF-α, IL-6 and IL-8 after PRRSV infection and thereby inhibit viral replication and propagation during the early stages of viral infection ([@B50]). *Sasa quelpaertensis* Nakai extracts have also been reported to significantly reduce the overexpression of proinflammatory cytokines including IL-1a, IL-6, IL-8, IL-15, and TNF-α and synergistically induced the expression of chemokines including IRFs, TLRs, and genes involved in the antiviral immune responses in SQE-treated PRRSV-infected cells. The intervention of SQE disrupted the mechanism with which PRRSV escapes the host innate defense system through the expression of immune-related genes which facilitated the suppression of PRRSV replication *in vitro* ([@B68]).

Down-Regulation IL-10 by Suppressing N Protein {#S4.SS6}
----------------------------------------------

The pleiotropic IL-10 is an essential cytokine involved in the persistence of viral infection. The expression of IL-10 is up-regulated by N protein which is dependent on the activation of NF-κB. Sodium tanshinone IIA sulfonate (STS) down-regulated IL-10 cytokine expression through the suppression of N protein. STS was observed to attenuate the persistence of PRRSV by down-regulating the expression of IL-10 as a result of the inhibition of transcription and translation of PRRSV N protein which concomitantly led to reduced cell apoptosis ([@B137]).

Deactivation of the NF-κB Pathway {#S4.SS7}
---------------------------------

It was also observed that Proanthocyanidin A2 (PA2) inhibited the release of PRRSV progeny particles by blocking the NF-κB pathway. It is present as a dimer of proanthocyanidins in plants tissues. It is produced from the condensation of catechins ([@B41]). PA2 and its derivatives exhibit antiviral activities against HSV, Coxsackie B virus (CBV), and CDV ([@B44]), by multiple mechanisms depending on the strain of the virus. PA2 inhibited PPRSV infections *in vitro* and targeted the various stages of PPRSV infection including the viral entry, internalization, viral packaging and progeny release phases of the life cycle of PRRSV through numerous mechanisms ([@B182]). PA2 significantly reduced the numbers of PRRSV particles in treated MARC 145 and PAM cells. [@B182] postulated that the antiviral mechanism of PA2 against PRRSV might be mediated directly through structural alteration or viral inactivation and indirectly through its antioxidant activity. The antioxidant and antidepressant activities of PA2 have been reported ([@B97]; [@B173]). Interestingly, PRRSV infection is known to induce oxidative stress in cells by generating ROS, thereby leading to the activation of NF-κB pathway, a very significant pathway in PRRSV pathogenesis ([@B80]). It was therefore inferred that PA2 could indirectly inhibit PRRSV packaging and assembly by inhibiting the activation of NF-κB biosynthesis. However, this needs to be investigated further. See [Table 4](#T4){ref-type="table"} for the summary.

###### 

Immunomodulators and PRRSV pathogenic pathways inhibitors.

  TCMs                                           Compounds                                Antiviral strategy                                                                                    Mechanism                                                                                              References
  ---------------------------------------------- ---------------------------------------- ----------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------ ------------
  *Forsythia suspense* Vahl                      Forsythoside A                           Inhibits the replication of PRRSV Reduces the viral RNA copies at the intracellular level             Strongly induces the production of IFN-α in a dose-dependent manner                                    [@B174]
  *Sophora flavescens Ait*                       Matrine                                  Significantly inhibited the secretion of IL-1β                                                        Abrogated the NF-κB signaling pathway by deactivating the expression of MyD88 and NLRP3 inflammasome   [@B141]
  Green Tea (*Camellia sinensis*)                (--)-epigallocatechin-3-gallate (EGCG)   Inhibits early stage viral replication                                                                Reverses the increased expression of mRNA transcripts encoding TNF-α, IL-6, and IL-7                   [@B50]
  *Salvia miltiorrhiza*                          Tanshinone IIA sulfonate (STS)           Inhibits PRRSV replication                                                                            Down-regulates IL-10 cytokine expression through the suppression of N protein                          [@B139]
  Licorice roots (*Glycyrrhiza glabra*)          Dipotassium glycyrrhetate                Inhibits PRRSV replication Impairs viral assembly                                                     Inhibits the expression of N protein by modulating the expression of IFNs                              [@B163]
  Rhizomes of *Dryopteris crassirhizoma* Nakai   Flavaspidic Acid Ab (Fa-Ab)              Inhibits PRRSV replication                                                                            Induces the expression of IFN-α, IFN-β, and interleukin-1β                                             [@B175]
  Grape seed *Vitis vinifera*                    Proanthocyanidin A2 (PA2)                Multiple Strategies: Blocks viral attachment, internalization, viral packaging, and progeny release   Inhibits the release of PRRSV progeny particles by deactivating the NF-κB pathway                      [@B182]

Conclusion {#S5}
==========

One of the most ubiquitous and notorious viral diseases that pose a perennial threat to the survival of the global swine industry is PRRS. The current attempts to control the disease, including the application of vaccines and veterinary medicine have not achieved the expected result, and the reliable control of PRRSV is presently beyond our reach. The pathway toward PRRS control and the economic importance of swine for human life drive the search for novel, innovative, and alternative strategies for the effective control of the disease, and TCM has proven to have a promising potential in bridging this gap ([@B107]).

The antiviral strategies of TCMs are due to their bioactive ingredients. The pathway forward must be built on a real understanding of the mechanisms by which TCMs exerts their effects. Studies focused on the antiviral effect of TCMs against PRRSV have shown that the bioactive ingredients have both direct and indirect inhibition effects on the viral life cycle, including the entry blockers, replication inhibitors, packaging and assembly inhibitors, immunomodulators and pathogenic pathways inhibitors ([@B50]; [@B140]; [@B181], [@B182]). These observations raise questions that must be considered in making plans for further research, i.e., the specific mechanism of interaction between the bioactive compounds in herbal extracts and PRRSV virulent proteins; the standard procedures to support the efficacy of available TCMs especially through controlled laboratory and clinical trials; and harness the active bioactive components in TCM materials through combined intervention to synergistically achieve significant effects at extremely low doses. Even more intriguing is on-going research based on advanced techniques and the collaborations in the areas of bioinformatics, chemistry, and proteomics could lead to the availability of sufficient data to support the efficacy, safety, and quality control levels of TCMs without any breach of data integrity and good manufacturing practices.

This review has provided a summary of some TCMs with observed biological activities against the different stages of the life cycle of PRRSV. Two major categories of TCMs were outlined based on their observed mode of actions, including those that directly target a specific stage in the life cycle of the virus (direct-acting antivirals -DAAs) such as entry blockers, replication inhibitors, packaging and assembly inhibitors, and those that indirectly inhibit the growth of the virus through the modification of the host immune system (indirect-acting antivirals -IAAs) such as immunomodulators and inhibitors of metabolic pathways that promote PRRSV pathogenesis.
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CD163

:   cluster of differentiation 163

CD169

:   cluster of differentiation 169

CDV

:   Canine Distemper Virus

CFDA

:   China Food and Drug Administration

DC --SIGN

:   dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin/CD209 (cluster of differentiation 209)

EAV

:   Equine arteritis virus

ERKs/ERK1/2

:   Extracellular signal--regulated kinases/Extracellular signal--regulated kinases 1/2

FDA

:   Food and Drug Administration

H5N1

:   hemagglutinin-5 and neuraminidase-1

HBV

:   hepatitis B virus

HCV

:   hepatitis C virus

HIV

:   human immunodeficiency virus

HS

:   heparan sulfate

HSV

:   herpes simplex virus

ICD

:   International Statistical Classification of Diseases

IFN-γ

:   interferon gamma

IL

:   interleukin

INF-α

:   interferon alpha

INF-β

:   interferon beta

IPMA

:   immunoperoxidase monolayer assay

LDV

:   lactate dehydrogenase-elevating virus

LV

:   lelystad virus

MARC 145

:   Meat Animal Research Center-145 Cell line

MHCII-A

:   major histocompatibility complex class II antigen molecules

MLV

:   modified live vaccines

MYH9

:   non-muscle myosin heavy chain 9

NADC 30

:   National Animal Disease Center 30 PRRSV strain

NF-κB

:   nuclear factor kappa-light-chain-enhancer of activated B cells

NK

:   natural killer cells

NNI

:   non-nucleoside inhibitors

NS5B RdRp

:   non-structural protein 5B RNA-dependent RNA polymerase

NSP9

:   non-structural protein 9

p107

:   retinoblastoma-like protein 1

PAM

:   porcine alveolar macrophage

PCD163

:   porcine cluster of differentiation 163

PERK

:   protein kinase R (PKR)-like endoplasmic reticulum kinase

PRRSV

:   porcine reproductive and respiratory syndrome virus

RdRp

:   RNA-dependent RNA polymerase

ROS

:   reactive oxygen species

SARS

:   severe acute respiratory syndrome

SARS-CoV

:   SARS coronavirus

SHFV

:   simian hemorrhagic fever virus

TCM

:   Traditional Chinese Medicine

Th1

:   T helper 1 (cells or cytokines)

TNF-α

:   tumor necrosis factor alpha

WHO

:   World health Organization.
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